A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of TRV130 in Patients Experiencing Moderate to Severe Acute Pain

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of TRV130 in Patients Experiencing Moderate to Severe Acute Pain

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Oliceridine (Primary)
  • Indications Acute pain
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Trevena
  • Most Recent Events

    • 11 Jun 2014 According to the Trevena media release, first part of this trial is completed and second part of the study, which tests the effects of subjects metabolic capacity on TRV 130 potential duration of action is in progress.
    • 11 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top